Novartis India is 76% subsidiary of Swiss drug major Novartis AG.Company's Indian operations can be classified into Pharmaceuticals, Generics, OTC and Animal Health.Novaris have some good brands like Voveran,Otrivin ..etc Company also own some popular brands like Sandimmun, Neoral,Tegrital.
In the animal health division company's brands include Natuzyme,Denagard..etc.
In 2009 ,company came out with an open offer and raised the parent's stake to current level.
In recent times company showing aggressiveness in development and marketing of new products especially in
Cough, Cold, and Allergy category. Reflection of the same is already visible in its financials.
For the latest December quarter company posted a turnover of Rs.184 Cr ( Rs.160 Cr) and a net profit of RS.41 Cr (Rs.23 Cr) Full year EPS is expected around Rs.48/-.Along with good prospects of pharma industry in India due to increasing health awareness and government focus,company's better commitment after hiking its parent's stake is expected to augurs well for Novartis going forward.At CMP of Rs.622,Novartis is a good bet from pharma sector.
